Multivariate optimization of a novel electrode film architecture containing gold nanoparticle-decorated activated charcoal for voltammetric determination of levodopa levels in pre-therapeutic phase of Parkinson`s disease

Highly efficient electrocatalytic oxidation of levodopa as a Parkinson therapeutic drug based on modified screen-printed electrode

The current study presents the creation of a straightforward and sensitive sensor based on ZnO/Co3O4 nanocomposite modified screen-printed electrode (ZnO/Co3O4NC/SPE) for levodopa determination. At ZnO/Co3O4NC/SPE, an oxidative peak for levodopa solution in pH 6.0 phosphate buffer solution (PBS) were seen that were both more resolved and more enhanced. Levodopa was measured using differential pulse voltammetry (DPV), which showed an excellent linear range (0.001-800.0 μM) and detection limit (0.81 nM). The presence of interference did not affect the electrochemical response of levodopa at ZnO/Co3O4NC/SPE, demonstrating high selectivity. Levodopa in a real samples have been successfully detected using the manufactured sensor.

Tapered cross-linked ZnO nanowire bundle arrays on three-dimensional graphene foam for highly sensitive electrochemical detection of levodopa

It is crucial to accurately and rapidly monitor the levodopa (LD) concentration for accurate classification and treatment of dyskinesia in Parkinson's disease. In this paper, 3D graphene foam (GF) with a highly conductive network is obtained by chemical vapor deposition. 3D GF serves as the substrate for hydrothermal in situ growth of tapered cross-linked ZnO nanowire bundle arrays (ZnO NWBAs), enabling the development of a highly sensitive detection platform for LD. The formation mechanism of a tapered cross-linked ZnO nanowire bundle arrays on 3D GF is put forward. The integration of 3D GF and ZnO NWBAs can accelerate the electron transfer rate and increase the contact area with biomolecules, resulting in high electrochemical properties. The electrode composed of ZnO NWBAs on 3D GF exhibits significant sensitivity (1.66 µA·µM-1·cm-2) for LD detection in the concentration range 0-60 µM. The electrode is able to rapidly and specifically determine LD in mixed AA or UA solution. The selectivity mechanism of the electrode is also explained by the bandgap model. Furthermore, the successful detection of LD in serum demonstrates the practicality of the electrode and its great potential for clinical application.

Voltammetric Sensing of Nifedipine Using a Glassy Carbon Electrode Modified with Carbon Nanofibers and Gold Nanoparticles

Nifedipine, a widely utilized medication, plays a crucial role in managing blood pressure in humans. Due to its global prevalence and extensive usage, close monitoring is necessary to address this widespread concern effectively. Therefore, the development of an electrochemical sensor based on a glassy carbon electrode modified with carbon nanofibers and gold nanoparticles in a Nafion® film was performed, resulting in an active electrode surface for oxidation of the nifedipine molecule. This was applied, together with a voltammetric methodology, for the analysis of nifedipine in biological and environmental samples, presenting a linear concentration range from 0.020 to 2.5 × 10-6 µmol L-1 with a limit of detection 2.8 nmol L-1. In addition, it presented a good recovery analysis in the complexity of the samples, a low deviation in the presence of interfering potentials, and good repeatability between measurements.

Surface imprinting by using bi-functional monomers on spherical template magnetite for selective detection of levodopa in biological fluids

The present work introduces an innovative biosensing platform for greatly sensitive determination of levodopa medicine. Initially, spherical magnetic (SM) nanoparticles were prepared by hydrothermal fabrication approach and used as a pattern to make spherical magnetic molecular imprinted polymer (SMMIP). Afterward, levodopa-molecularly imprinted layer was grown on the surface of the spherical magnetic pattern by electropolymerization with dopamine and resorcinol as bi-functional monomers and levodopa as a template molecule, which enhanced the specific recognition of the sensing platform to levodopa. The presence of SM nanoparticles could not only accelerate the mass transfer, the electron transport rate, and improve specific surface area of the electrode but also facilitate the recognition of the polymer, in this way increasing the current response and improving the performance of the biosensor. The superior sensing efficiency of the presented biosensor was confirmed based on the low limit of detection of 10 nmol L^-1 which represented two linear ranges from 0.5 to 200 μmol L^-1 and 200-1000 μmol L^-1 for levodopa. More importantly, the practicability of the biosensor was proved by detecting levodopa in tablet, blood serum and plasma, implying that the sensing platform was suitable for monitoring levodopa in actual biological fluid and medicine.